0.32

3.19% 0.0099

After Hours: .31 -0.01 -3.13%

IGC Pharma Inc (IGC)

Overview News Price History Option Chain Discussions Forecast Stock Split

IGC Pharma Inc stock is traded at $0.32, with a volume of 237.88K. It is up +3.19% in the last 24 hours and up +13.07% over the past month. India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.

Previous Close:

$0.3101

Open:

$0.313

24h Volume:

237.88K

Relative Volume:

0.65

Market Cap:

$31.61M

Revenue:

$1.20M

Net Income/Loss:

$-5.34M

P/E Ratio:

-5.178

EPS:

-0.0618

Net Cash Flow:

$-6.27M

1W Performance:

+14.29%

1M Performance:

+13.07%

6M Performance:

-22.48%

1Y Performance:

+10.12%

1-Day Range:

$0.31

$0.32

1-Week Range:

$0.28

$0.32

52-Week Range:

$0.242

$0.4985

IGC Pharma Inc Stock (IGC) Company Profile

Name

IGC Pharma Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

301-983-0998

Address

4336 Montgomery Avenue, Bethesda, MD

Employee

Twitter

@IGCIR

Next Earnings Date

2026-04-03

Latest SEC Filings

IGC's Discussions on Twitter

Compare IGC vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IGC IGC Pharma Inc	0.32	30.64M	1.20M	-5.34M	-6.27M	-0.0618
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

IGC Pharma Inc Stock (IGC) Latest News

04:15 AM

IGC Advances Patient Enrollment in Alzheimer's Clinical Trial - GuruFocus

04:15 AM

Apr 14, 2026

IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout - Finviz

Apr 14, 2026

IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout (2026-04-14) - Seeking Alpha

Apr 14, 2026

Apr 13, 2026

What is IGC Pharma Incs valuation compared to sector2026 Fundamental Recap & Reliable Breakout Forecasts - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

IGC Pharma (IGC) price target increased by 10.34% to 4.08 - MSN

Apr 12, 2026

Apr 11, 2026

New to The Street Broadcasts on Bloomberg TV, Featuring IGC, VVOS, ACXP, and EQX - National Today

Apr 11, 2026

New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Idaho Statesman

Apr 11, 2026

Apr 10, 2026

IGC Pharma Share Price Target and Forecast - Investing.com India

Apr 10, 2026

Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts - 富途牛牛

Apr 10, 2026

Apr 09, 2026

IGC Pharma (NYSEAMERICAN:IGC) Given New $5.25 Price Target at Ascendiant Capital Markets - Defense World

Apr 09, 2026

Apr 08, 2026

Analyst lifts IGC Pharma target to $5.25 as Alzheimer’s trial advances - Stock Titan

Apr 08, 2026

IGC Pharma (NYSEAMERICAN:IGC) Shares Up 0.9% – Still a Buy? - Defense World

Apr 08, 2026

IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill

Apr 08, 2026

Apr 07, 2026

IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease - marketscreener.com

Apr 07, 2026

IGC Pharma (IGC) PFO Claudia Grimaldi exercises RSUs and options for more shares - Stock Titan

Apr 06, 2026

Apr 03, 2026

IGC.WS (India Globalization Capital) PB Ratio : (As of Apr. 03, 2026) - GuruFocus

Apr 03, 2026

Mar 31, 2026

How does IGC Pharma Inc perform in inflationary periodsWeekly Gains Report & Technical Buy Zone Confirmations - baoquankhu1.vn

Mar 31, 2026

IGC Pharma Launches National Media Partnership to Boost Visibility - The Globe and Mail

Mar 31, 2026

Mar 30, 2026

IGC Pharma Launches Strategic National Media Partnership with Ne - GuruFocus

Mar 30, 2026

Aug Breakouts: Should I trade or invest in IGC Pharma Inc2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn

Mar 30, 2026

Signal Recap: What is IGC Pharma Incs valuation compared to sectorQuarterly Portfolio Review & Comprehensive Market Scan Insights - baoquankhu1.vn

Mar 30, 2026

Performance Recap: What is IGC Pharma Incs book value per shareMarket Growth Review & Stock Market Timing Techniques - baoquankhu1.vn

Mar 30, 2026

IGC Pharma launches 12-part national media campaign with New to The Street to boost investor awareness - TradingView — Track All Markets

Mar 30, 2026

IGC Pharma (NYSE: IGC) inks 12-part New to The Street deal - Stock Titan

Mar 30, 2026

Aug Shorts: What is IGC Pharma Incs book value per share2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn

Mar 30, 2026

IGC Pharma Partners with New to The Street for National Media Campaign - National Today

Mar 30, 2026

IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - biospace.com

Mar 30, 2026

IGC Pharma Launches Strategic National Media Partnership With New to The Street to Expand Investor Awareness - 富途牛牛

Mar 30, 2026

Mar 28, 2026